ask="N/A"
ask_size="N/A"
average_daily_volume="72460"
bid="8.50"
bid_size="900"
book_value="3.83"
change="+0.09"
change_from_200_day_moving_average="-1.47"
change_from_50_day_moving_average="-0.60"
change_from_52_week_high="-6.78"
change_From_52_week_low="0.83"
change_in_percent="+1.00%"
close="9.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.85"
ebitda="-19.31M"
eps_estimate_current_year="-1.80"
eps_estimate_next_quarter="-0.46"
eps_estimate_next_year="-1.71"
ex_dividend_date="N/A"
float_shares="7487000"
high="9.18"
high_52_weeks="15.88"
last_trade_date="3/9/2017"
last_trade_price="9.10"
last_trade_size="275"
last_trade_time="4:00pm"
low="9.00"
low_52_weeks="8.27"
market_capitalization="152.63M"
moving_average_200_day="10.57"
moving_average_50_day="9.70"
name="Obalon Therapeutics
Inc."
notes="N/A"
one_year_target_price="19.75"
open="9.07"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-13.92%"
percent_change_from_50_day_moving_average="-6.21%"
percent_change_from_52_week_high="-42.70%"
percent_change_from_52_week_low="+10.04%"
previous_close="9.01"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.35"
price_per_sales="44.54"
revenue="3.39M"
shares_outstanding="16773000"
short_ratio="9.69"
stock_exchange="NGM"
symbol="OBLN"
volume="25759"
weeks_range_52="8.27 - 15.88"
